Related Experiment Video
Updated: Oct 14, 2025
11:27
Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
16.8K
Lipid metabolism reprogramming in renal cell carcinoma
Gioia Heravi1, Omid Yazdanpanah2, Izabela Podgorski3,4,5
1Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA.
Cancer Metastasis Reviews
|November 6, 2021
Summary
Metabolic reprogramming, particularly lipid metabolism, is crucial for cancer survival. This review highlights the role of cholesterol, free fatty acids (FFAs), and polyunsaturated fatty acids (PUFAs) in renal cell carcinoma (RCC) development and offers insights for new therapies.
Area of Science:
- Oncology
- Cancer Biology
- Metabolic Research
Background:
- Metabolic reprogramming is a cancer hallmark, enabling tumor survival in nutrient-poor conditions.
- Lipid metabolism alterations are critical for cancer cells, but less studied in renal cell carcinoma (RCC).
- Metastatic RCC presents treatment challenges due to chemoresistance and limited targeted therapies.
Purpose of the Study:
- To review the role of lipid metabolism in renal cell carcinoma (RCC) pathogenesis.
- To explore the significance of cholesterol, free fatty acids (FFAs), and polyunsaturated fatty acids (PUFAs) in RCC.
- To identify potential therapeutic targets by understanding lipid reprogramming in RCC.
Main Methods:
- Literature review of recent findings on lipid metabolism in RCC.
- Analysis of the synthesis and metabolism of key lipids (cholesterol, FFAs, PUFAs) in cancer.
- Examination of the link between lipid reprogramming and RCC biology.
Main Results:
- Altered lipid metabolism, including cholesterol, FFAs, and PUFAs, is implicated in RCC carcinogenesis.
- Lipid reprogramming supports RCC cell survival and proliferation.
- Understanding these mechanisms is vital for advancing RCC treatment.
Conclusions:
- Lipid metabolism reprogramming is a significant factor in RCC development and progression.
- Targeting lipid pathways presents a promising avenue for novel RCC therapeutic strategies.
- Further research into RCC lipidomics can improve patient outcomes.
Related Concept Videos
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
20
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
20
01:22PI3K/mTOR/AKT Signaling Pathway
4.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.2K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:28Chronic Kidney Disease III: Interprofessional Care
108
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
108
01:20Renal Corpuscle
3.8K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
3.8K